These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 786281)

  • 1. A radiometric method for the measurement of L-asparaginase at concentrations below 1 X 10(-5) I.U./ml: technique and application.
    Cooney DA; Milman HA; Taylor B
    Biochem Med; 1976 Apr; 15(2):190-205. PubMed ID: 786281
    [No Abstract]   [Full Text] [Related]  

  • 2. A simple and rapid method for the estimation of L-asparaginase in chromatographic and electrophoretic effluents: comparison with other methods.
    Jayaram HN; Cooney DA; Jayaram S; Rosenblum L
    Anal Biochem; 1974 Jun; 59(2):327-46. PubMed ID: 4599360
    [No Abstract]   [Full Text] [Related]  

  • 3. A colorimetric technique for the demonstration of L-asparaginase in electropherograms.
    Cooney DA; Moore AL; Zhagats R
    Clin Chim Acta; 1972 Aug; 40(1):249-57. PubMed ID: 4626844
    [No Abstract]   [Full Text] [Related]  

  • 4. Some physicochemical aspects of L-asparaginase therapy.
    Mashburn LT; Landin LM
    Recent Results Cancer Res; 1970; 33():48-63. PubMed ID: 4949169
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases.
    Roberts J; Schmid FA; Old LJ; Stockert E
    Cancer Biochem Biophys; 1976 May; 1(4):175-8. PubMed ID: 788892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of L-asparaginase from Erwinia aroideae and from Escherichia coli: biochemical and biological properties.
    Staerk J; Zwisler O; Ronneberger H
    Experientia; 1971 Mar; 27(3):250-2. PubMed ID: 4993733
    [No Abstract]   [Full Text] [Related]  

  • 7. L-asparaginase: a review.
    Wriston JC; Yellin TO
    Adv Enzymol Relat Areas Mol Biol; 1973; 39():185-248. PubMed ID: 4583638
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the embryotoxic activity of L-asparaginase.
    Adamson RH; Fabro S; Hahn MA; Creech CE; Whang-Peng J
    Arch Int Pharmacodyn Ther; 1970 Aug; 186(2):310-20. PubMed ID: 4943133
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of the iso-electric point of L-asparaginase upon its persistence in the blood.
    Rutter DA; Wade HE
    Br J Exp Pathol; 1971 Dec; 52(6):610-4. PubMed ID: 4944363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of immunization to L-asparaginase on antitumor and enzymatic activity.
    Goldberg AI; Cooney DA; Glynn JP; Homan ER; Gaston MR; Milman HA
    Cancer Res; 1973 Feb; 33(2):256-61. PubMed ID: 4569788
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of Erwinia carotovora and Escherichia coli L-asparaginases and their subunits.
    Miller DS; Marlborough DI; Cammack KA
    J Gen Microbiol; 1971 Mar; 65(3):ii. PubMed ID: 4933808
    [No Abstract]   [Full Text] [Related]  

  • 12. The partitioning of L-asparaginase between blood and lymph.
    Hall JG
    Recent Results Cancer Res; 1970; 33():75-80. PubMed ID: 4949170
    [No Abstract]   [Full Text] [Related]  

  • 13. Automated determination of bacterial asparaginase and glutaminase.
    Wade HE; Phillips BP
    Anal Biochem; 1971 Nov; 44(1):189-99. PubMed ID: 4943713
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous assays of L-asparaginase by coupling with glutamic dehydrogenase and by cationic glass electrode.
    Ferguson DA; Boyd JW; Phillips AW
    Anal Biochem; 1974 Nov; 62(1):81-90. PubMed ID: 4611274
    [No Abstract]   [Full Text] [Related]  

  • 15. Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli.
    Ohnuma T; Holland JF; Meyer P
    Cancer; 1972 Aug; 30(2):376-81. PubMed ID: 4559405
    [No Abstract]   [Full Text] [Related]  

  • 16. Microcalorimetric determination of substrate specificity of L-asparaginase in Escherichia coli and Erwinia carotovora.
    Rekharsky MV; Egorov AM; Bankovskaya SA; Ozoliņa RK; Vĩna IA; Berziņa-Berzĩte RV; Lopatnev SV; Galchenko GL
    J Biochem Biophys Methods; 1988 Aug; 16(4):319-21. PubMed ID: 3065395
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system.
    Albertsen BK; Schrøder H; Ingerslev J; Jakobsen P; Avramis VI; Müller HJ; Carlsen NT; Schmiegelow K
    Br J Haematol; 2001 Dec; 115(4):983-90. PubMed ID: 11843837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
    Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):57-60. PubMed ID: 8039761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.
    Broome JD
    Br J Cancer; 1968 Sep; 22(3):595-602. PubMed ID: 4878639
    [No Abstract]   [Full Text] [Related]  

  • 20. L-asparaginase from Erwinia carotovora. Substrate specificity and enzymatic properties.
    Howard JB; Carpenter FH
    J Biol Chem; 1972 Feb; 247(4):1020-30. PubMed ID: 5010061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.